Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013324 |
---|---|
Receipt number | R000015551 |
Scientific Title | A phase II study of resection followed capecitabine + oxaliplatin for liver metastasis of colorectal cancer. [REX study] |
Date of disclosure of the study information | 2014/03/04 |
Last modified on | 2022/04/26 13:49:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/03/04 11:51:27 | ||
2 | Update | 2014/10/11 17:30:13 | Name of person sending information Name of person sending information Division name Division name |
|
3 | Update | 2017/09/05 19:20:31 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
4 | Update | 2022/02/09 15:44:32 | UMIN ID1 |
|
5 | Update | 2022/03/18 10:38:45 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
6 | Update | 2022/03/18 10:42:37 | Recruitment status Date of IRB Last follow-up date |
|
7 | Update | 2022/03/18 10:44:39 | Publication of results Number of participants that the trial has enrolled |
|
8 | Update | 2022/04/26 13:49:22 | Recruitment status |